Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
17.09
-0.12 (-0.70%)
Dec 20, 2024, 4:00 PM EST - Market closed
Rigel Pharmaceuticals Employees
Rigel Pharmaceuticals had 147 employees as of December 31, 2023. The number of employees decreased by 8 or -5.16% compared to the previous year.
Employees
147
Change (1Y)
-8
Growth (1Y)
-5.16%
Revenue / Employee
$1,070,571
Profits / Employee
$26,401
Market Cap
301.04M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cerus | 637 |
Sage Therapeutics | 487 |
AVITA Medical | 207 |
Voyager Therapeutics | 162 |
Nyxoah | 147 |
Silence Therapeutics | 109 |
Aclaris Therapeutics | 91 |
enGene Holdings | 33 |
RIGL News
- 12 days ago - Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition - PRNewsWire
- 19 days ago - Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS - PRNewsWire
- 5 weeks ago - Rigel to Present at the Jefferies London Healthcare Conference - PRNewsWire
- 6 weeks ago - Rigel Pharmaceuticals, Inc. (RIGL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update - PRNewsWire
- 6 weeks ago - Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition - PRNewsWire
- 7 weeks ago - Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update - PRNewsWire
- 2 months ago - Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib) - PRNewsWire